John Chionis

John Chionis has over 20 years of work experience in the biotechnology and pharmaceutical industry. John currently serves as an Associate Director at Genesis Therapeutics, a position they have held since April 2023. Prior to this role, they worked as a Scientist at Genesis Therapeutics from July 2021 to April 2023. Before joining Genesis Therapeutics, John was employed at Pfizer, where they held various positions, including Principal Scientist from November 2019 to July 2021, Senior Scientist from January 2014 to November 2019, and Scientist from February 2008 to January 2014. Additionally, they have worked at PacificGMP as a Quality Control professional from June 2006 to November 2010, and at ItherX Pharmaceuticals, Inc. as a Research Associate in January and February 2008. Earlier in their career, John also worked at Immusol and Symbigene as a Research Associate from June 2004 to January 2008 and from June 2001 to June 2004, respectively.

John Chionis pursued a degree in Molecular and Cellular Biology at the University of California, Davis. The exact start and end years of their education were not provided.